In a 54-year-old woman with reddened knuckles, what is the appropriate diagnostic work‑up and initial management?

Diagnostic Work-Up for Reddened Knuckles in a 54-Year-Old Woman

The most critical first step is to determine whether the reddened knuckles represent true inflammatory synovitis versus non-inflammatory skin thickening, because this distinction fundamentally changes the diagnostic pathway and urgency of referral.

Immediate Clinical Assessment

Perform a focused joint examination to identify definite clinical synovitis—characterized by soft, boggy tissue swelling around the joints, not hard bony enlargement—which is the cornerstone of inflammatory arthritis diagnosis. 1

Key Physical Examination Findings to Document:

• Assess for symmetric involvement of metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, and wrists, as this pattern is characteristic of rheumatoid arthritis 1, 2
• Perform the "squeeze test" by compressing across the MCPs and metatarsophalangeal (MTP) joints; pain on compression indicates synovitis and supports inflammatory arthritis 1, 3
• Document morning stiffness duration: stiffness lasting ≥30 minutes (ideally ≥1 hour) strongly suggests inflammatory arthritis such as rheumatoid arthritis, while stiffness <30 minutes is more consistent with osteoarthritis 1, 3
• Examine the skin carefully for psoriatic plaques, nail changes (pitting, onycholysis), or dactylitis to evaluate for psoriatic arthritis 4, 1
• Look for rheumatoid nodules on extensor surfaces, which indicate more severe disease 1
• Assess distal interphalangeal (DIP) joints: DIP involvement with sparing of MCPs suggests osteoarthritis or psoriatic arthritis rather than rheumatoid arthritis 1, 3

Critical Differential: Knuckle Pads vs. Inflammatory Arthritis

If the "reddened knuckles" are painless, firm subcutaneous nodules overlying the dorsal PIP joints without true joint swelling, consider knuckle pads—a benign fibromatosis that is frequently misdiagnosed as arthritis. 5, 6 Knuckle pads are well-circumscribed, subcutaneous hypoechoic masses on ultrasound without internal flow signals on color Doppler, distinguishing them from inflammatory synovitis which shows hyperemia. 6

Essential Laboratory Work-Up

Order the following tests simultaneously at initial presentation:

• Rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP/ACPA) are the cornerstone serologic tests; anti-CCP has 90% specificity and 60% sensitivity for rheumatoid arthritis, while RF has 70% specificity 1, 2
• C-reactive protein (CRP) is preferred over ESR because it is more reliable and not age-dependent; markedly elevated CRP (>10 mg/L) strongly suggests inflammatory arthritis 1, 2
• Erythrocyte sedimentation rate (ESR) should also be obtained at baseline for diagnostic and prognostic purposes 1
• Complete blood count with differential to assess for cytopenias before starting disease-modifying antirheumatic drugs (DMARDs) 1, 2
• Comprehensive metabolic panel including liver function tests, renal function, glucose, and urate levels for baseline safety assessment 1
• Urinalysis as part of the standard initial work-up 1, 2

Additional Testing When Diagnosis Is Uncertain:

• Antinuclear antibodies (ANA) to screen for other connective tissue diseases like systemic lupus erythematosus if the diagnosis remains unclear 1, 2
• HLA-B27 typing if clinical features suggest spondyloarthropathy, reactive arthritis, or if RF and anti-CCP are negative 1

Baseline Imaging Studies

Obtain bilateral hand, wrist, and foot radiographs (posteroanterior views) at initial presentation to assess for periarticular osteopenia, uniform joint space narrowing, and marginal erosions—hallmarks of rheumatoid arthritis. 4, 1, 2 The presence of erosions on baseline radiographs is highly predictive of rheumatoid arthritis diagnosis and persistent disease. 1

Advanced Imaging When Clinical Examination Is Equivocal:

• Ultrasound with Power Doppler is superior to clinical examination for detecting synovitis and structural damage, increasing detection of subclinical synovitis by approximately 75% 4, 1
• MRI with intravenous contrast is more sensitive than ultrasound in early disease and detects bone marrow edema (osteitis), which is the strongest single predictor of future radiographic progression and functional decline 4, 1
• Consider advanced imaging if the patient does not meet 2010 ACR/EULAR classification criteria but clinical suspicion remains high 1

Application of 2010 ACR/EULAR Classification Criteria

Calculate the classification score based on four domains:

Domain	Scoring
Joint involvement	1 large joint = 0 pts; 2-10 large joints = 1 pt; 1-3 small joints = 2 pts; 4-10 small joints = 3 pts; >10 joints = 5 pts [1]
Serology	Negative RF & ACPA = 0 pts; Low-positive RF or ACPA = 2 pts; High-positive RF or ACPA = 3 pts [1]
Acute-phase reactants	Normal CRP & ESR = 0 pts; Abnormal CRP or ESR = 1 pt [1]
Symptom duration	<6 weeks = 0 pt; ≥6 weeks = 1 pt [1]

A total score ≥6/10 points classifies the patient as having definite rheumatoid arthritis. 1

Critical Pitfalls to Avoid

• Do not delay treatment or referral waiting for positive serology—seronegative rheumatoid arthritis accounts for 20-30% of cases and has a prognosis similar to seropositive disease 1
• Do not dismiss the diagnosis based on normal ESR/CRP—acute-phase reactants can be normal in up to 20% of patients with active inflammatory arthritis 1
• Do not confuse knuckle pads (benign subcutaneous nodules) with inflammatory arthritis—knuckle pads are painless, firm, and lack true joint swelling or hyperemia on Doppler ultrasound 5, 6
• Do not ignore the possibility of psoriatic arthritis—it can present with polyarticular involvement, elevated CRP, and negative RF; careful skin and nail examination is essential 4, 1

Urgent Rheumatology Referral

Refer to rheumatology within 6 weeks of symptom onset if any of the following are present:

• ≥2 clinically swollen joints and morning stiffness >30 minutes 2
• Positive squeeze test of MCPs or MTPs 2
• Elevated inflammatory markers (CRP or ESR) consistent with active inflammation 2
• Any clinical synovitis that cannot be better explained by an alternative diagnosis 2

Early specialist evaluation and treatment with DMARDs prevents irreversible joint damage in up to 90% of patients. 2

Initial Management While Awaiting Rheumatology

• Initiate symptomatic relief with NSAIDs (e.g., naproxen 500 mg twice daily) at the minimum effective dose for the shortest time possible 2
• Consider short-term low-dose prednisone (5-10 mg daily) as bridge therapy for temporary relief while awaiting DMARD effect 2
• Educate the patient on the importance of urgent rheumatology follow-up, expected symptoms, and smoking cessation 2